182 related articles for article (PubMed ID: 25330015)
21. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Romei C; Ciampi R; Elisei R
Nat Rev Endocrinol; 2016 Apr; 12(4):192-202. PubMed ID: 26868437
[TBL] [Abstract][Full Text] [Related]
23. Role of RET genetic variants in MEN2-associated pheochromocytoma.
Siqueira DR; Ceolin L; Ferreira CV; Romitti M; Maia SC; Maciel LM; Maia AL
Eur J Endocrinol; 2014 Jun; 170(6):821-8. PubMed ID: 24616415
[TBL] [Abstract][Full Text] [Related]
24. PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.
Halászlaki C; Tóbiás B; Balla B; Kósa JP; Horányi J; Bölöny E; Nagy Z; Speer G; Járay B; Székely E; Istók R; Székely T; Putz Z; Dank M; Lakatos P; Takács I
Endocr Pract; 2016 Sep; 22(9):1081-7. PubMed ID: 27214302
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.
Rotondi M; Ercolino T; Fonte R; Lagonigro MS; Leporati P; Villani L; La Manna L; Mannelli M; Chiovato L
J Endocrinol Invest; 2009 Feb; 32(2):115-8. PubMed ID: 19411807
[TBL] [Abstract][Full Text] [Related]
26. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
[TBL] [Abstract][Full Text] [Related]
27. [Genetic polymorphisms: implications in the pathogenesis of medullary thyroid carcinoma].
Rocha AP; Magalhães PK; Maia AL; Maciel LM
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):723-30. PubMed ID: 17891235
[TBL] [Abstract][Full Text] [Related]
28. Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.
Ceolin L; Romitti M; Siqueira DR; Vaz Ferreira C; Oliboni Scapineli J; Assis-Brazil B; Vieira Maximiano R; Dias Amarante T; de Souza Nunes MC; Weber G; Maia AL
PLoS One; 2016; 11(2):e0147840. PubMed ID: 26829565
[TBL] [Abstract][Full Text] [Related]
29. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
[TBL] [Abstract][Full Text] [Related]
30. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.
Penna-Martinez M; Ramos-Lopez E; Stern J; Kahles H; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
Thyroid; 2012 Jul; 22(7):709-16. PubMed ID: 22690899
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.
Cebrian A; Lesueur F; Martin S; Leyland J; Ahmed S; Luccarini C; Smith PL; Luben R; Whittaker J; Pharoah PD; Dunning AM; Ponder BA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6268-74. PubMed ID: 16091499
[TBL] [Abstract][Full Text] [Related]
32. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
[TBL] [Abstract][Full Text] [Related]
33. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
34. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
[TBL] [Abstract][Full Text] [Related]
35. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type.
Inaba M; Umemura S; Satoh H; Abe Y; Kurokawa K; Sakai H; Osamura RY
Pathol Int; 2003 Mar; 53(3):146-53. PubMed ID: 12608895
[TBL] [Abstract][Full Text] [Related]
36. RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.
Neocleous V; Skordis N; Portides G; Efstathiou E; Costi C; Ioannou N; Pantzaris M; Anastasiadou V; Deltas C; Phylactou LA
J Endocrinol Invest; 2011 Nov; 34(10):764-9. PubMed ID: 21422799
[TBL] [Abstract][Full Text] [Related]
37. The RET oncogene in papillary thyroid carcinoma.
Prescott JD; Zeiger MA
Cancer; 2015 Jul; 121(13):2137-46. PubMed ID: 25731779
[TBL] [Abstract][Full Text] [Related]
38. A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history.
Halkova T; Dvorakova S; Vaclavikova E; Sykorova V; Vcelak J; Sykorova P; Vlcek P; Reboun M; Katra R; Kodetova D; Schrumpf M; van Wezel T; Morreau H; Bendlova B
Hum Pathol; 2015 Dec; 46(12):1962-9. PubMed ID: 26472164
[TBL] [Abstract][Full Text] [Related]
39. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y
Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740
[TBL] [Abstract][Full Text] [Related]
40. Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma.
Stephens LA; Powell NG; Grubb J; Jeremiah SJ; Bethel JA; Demidchik EP; Bogdanova TI; Tronko MD; Thomas GA
Thyroid; 2005 Feb; 15(2):100-4. PubMed ID: 15753666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
